Table 1.
Baseline clinical characteristics of the studied population by NT-proBNP.
| Group A (NT pro-BNP < 474 pg/ml (N = 53) | Group B (NT pro-BNP ⩾ 474 pg/ml (N = 79) | p Value | |
|---|---|---|---|
| Median age (years) mean ± SD | 57.4 ± 9.9 | 59.8 ± 13.3 | >0.05 |
| Male gender (%) | 41 (77.4%) | 52 (65.8%) | >0.05 |
| Obesity (%) | 20 (37.7%) | 29 (36.7%) | >0.05 |
| BMI (mean ± SD) | 30.2 ± 5.99 | 30.4 ± 7.3 | >0.05 |
| Diabetes (%) | 37 (69.8%) | 54 (68.4%) | >0.05 |
| HTN (%) | 40 (75.5%) | 61 (77.2%) | >0.05 |
| Smoking (%) | 29 (54.7%) | 33 (41.8%) | >0.05 |
| Hyperlipidemia(%) | 49 (92.5%) | 68 (86.1%) | >0.05 |
| Previous MI (%) | 13 (24.5%) | 31 (39.2%) | >0.05 |
| History of angina (%) | 25 (47.2%) | 47 (59.5%) | >0.05 |
| Previous PCI(%) | 15 (28.3%) | 20 (25.3%) | >0.05 |
| History of CABG (%) | 5 (9.4%) | 7 (8.9%) | >0.05 |